Skip to main content

Publications

2023

8-Amide and 8-carbamate substitution patterns as modulators of 7-hydroxy-4-methylcoumarin's antidepressant profile: Synthesis, biological evaluation and docking studies.

Matos M J, Novo P, Mayán L, Torres I, Uriarte E, Yáñez M, Fontenla JÁ, Ortuso F, Alcaro S, Procopio F, Rodríguez-Franco MI, Val C, Loza MI, Brea J, Borges F, Viña D.
Volume 248, 15 February 2023, 115091
Pharmacology of Chronic Diseases

AT1 receptor autoantibodies mediate effects of metabolic syndrome on dopaminergic vulnerability

Maria A. Pedrosa, Carmen M. Labandeira, RitaValenzuela, Aloia Quijano, Mariña Sanchez-Andrade, Juan A. Suarez-Quintanilla, Jose L. Lanciego, Jose L. Labandeira-Garcia, Ana I. Rodriguez-Perez
Brain, Behavior, and Immunity, Volume 108, February 2023, Pages 255-268
Cell and Molecular Neurobiology of Parkinson's Disease

Cancer cells escape the immune system by increasing stemness through epigenetic reprogramming

Costoya, J.A., Arce, V.M.
Cell Mol Immunol 20, 6–7 (2023).
Molecular Oncology Laboratory

Caracterización clínica y terapéutica de la cardiopatía isquémicaen España. Importancia de los programas de rehabilitación cardiaca.

Cordero A., Campuzano Ruiz R., Cequier Fillat Á., López De Sá Areses E., González-Juanatey J.R., en representacion de los investigadores del estudio RECARIS
Medicina Clínica Práctica. Volume 5, Issue 3, July–September 2022
Cardiovascular Area

Characterization and Clinical Association of Autoantibodies Against Perilipin 1 in Patients With Acquired Generalized Lipodystrophy.

Corvillo F, Abel BS, López-Lera A, Ceccarini G, Magno S, Santini F, Araújo-Vilar D, Brown RJ, Nozal P, López-Trascasa M
Diabetes. 2023 Jan 1;72(1):71-84.
Molecular Pathology of Rare Diseases